Overview
A briefing from DIT officers based in LATAC countries about their respective Healthcare and Life Sciences markets and regulatory landscape. They will present which business opportunities they foresee for the year ahead, alongside top tips and success stories from UK companies operating in the region.
Speaker:
Juliana Caires, Regional Manager Healthcare and Life Sciences - Brazil & LATAC, Department for International Trade - Brazil & LATAC
With a background in International Relations and Global Health, I have been working for the British Government for the last 6 years, based in São Paulo - Brazil. I have previously led on political analysis and government affairs strategy for the British Consulate in São Paulo, and my current role is focused on regionally leading the DIT teams on trade promotion and overcoming market access barriers for British companies in the Healthcare and Life Sciences sectors.
Paul Alba, Regional Trade & Investment Advisor, DIT Panama
Paul Alba is part of the sub-regional team of DIT, based in Panama and supporting Central America and the Caribbean. He leads the Healthcare, Life Sciences, Education & Financial Services.
Rodrigo Acevedo, Business Development Officer, DIT Peru
Rodrigo “Rod” Acevedo is the Life Sciences & Healthcare Officer in DIT Peru, at the British Embassy in Lima. He leads DIT Peru’s relationship with public and private healthcare institutions, and is interested in expanding the market for UK companies in the pharmaceutical, medical equipment and digital health sectors. From his role, he is constantly scoping for new business opportunities in Peru, as well as developing new pipelines for quality and innovation in the local healthcare scene. Get in contact with him to know more about Peru, and the fast-growing set of opportunities in its healthcare market.
LinkedIn URL: www.linkedin.com/in/rodrigo-acevedo-22030234a136
Maria Alejandra Perez, Life Sciences Officer Colombia, Department for International Trade (DIT)
Maria Alejandra’s main work has been to support and guide foreign companies in the development of projects and commercial activities in Colombia. Likewise, she's currently working with regulatory agencies, ministries and all sort of stakeholders in the Colombian healthcare sector, to eliminate market access barriers for UK companies. Additionally, she has experience with regional governments through international cooperation healthcare projects (PPP). She has a Bachelor’s degree in Business Administration and a Master's degree in Public Policy at LSE.
Michael Wilkinson, PhD, CEO and Founder, Inavya
Michael is CEO and Founder of Inavya, which has created AVATR technology - a CE Marked medical device that deploys artificial intelligence to enable a person to create, own and share their digital profile to receive remote medical care. Michael is an appointed innovation expert to InnovateUK, the National Institute for Health Research (NIHR), the UK Government, and the European Commission. He earned a PhD from Warwick University Medical School, where he was Overseas Research Scholar and Research Fellow. At the London School of Hygiene and Tropical Medicine he was Lecturer in Health Informatics, Founder of a Health Informatics Lab, and Scientific Adviser to the WHO. Michael previously held an appointment as Assistant Director of Strategy at the Cabinet Office, where he led the Enabling a Digitally United Kingdom initiative on behalf of the government. While in post at Cabinet Office, he also wrote the business case for the NHS National Innovation Centre and subsequently led its development.
Julio Evaristo, Head of Education, Healthcare & Life Sciences, DIT Mexico
Julio is the Head of Education, Health and Life Sciences for DIT Mexico. For the past 5 years, he has applied his vast knowledge across the sectors by helping UK companies to establish in Mexico, strengthening existing bilateral relationships and raising awareness of potential opportunities in Mexico.
He is in charge of implementing the strategy for the education and health sectors, which aims to improve the awareness of innovative UK solutions into the Mexican market. He also has experience in working on Market Access issues to support the entry of new UK companies into the country enhancing the overall sector ecosystem.
Julio has previous experience in both public and private sector and holds an International Business Degree from IPN.
Anna Parker, Head of International Sales, Paxman Coolers Ltd
With an MSc in International Business Management, Anna held a variety of international business development roles in the healthcare sector prior to joining Paxman in 2017.
As Head of International Trade, Anna focuses on mobilising Paxman’s network of distributors and direct report Regional Managers to improve patient access to scalp cooling in rest of world markets.
Anna has been instrumental in bringing scalp cooling to markets historically having little awareness of the treatment such as Argentina and Mexico, whilst continuing to nurture Paxman’s numerous established markets. Anna has played a major role in instigating clinical trials around the world, collaborating closely with thought leaders and clinicians within the oncology space.
A keynote speaker at innumerable business launch events and attending major international oncology and supportive cancer care conferences around the world annually, Anna ensures best practice for scalp cooling as a means of side effect management is shared across Paxman’s network and beyond. She is passionate that every applicable cancer patient should have access to scalp cooling treatment, giving them the choice to retain their hair through chemotherapy.
Chemotherapy-induced hair loss is widely recognised as one of the most traumatic side effects associated with cancer treatment, and yet it is still one of the least explored. PAXMAN are changing that. The clinically proven PAXMAN cold cap system has helped over 100,000 cancer patients in more than 25 countries worldwide to retain their hair during chemotherapy.
Following graduation from Huddersfield University with an MSc in International Business Management, Anna worked in variety of international business development roles in the healthcare sector facilitating companies’ global growth prior to joining PAXMAN in 2017. Since then Anna’s focus is to continue the mobilisation of PAXMAN’s global network of distributors to improve the accessibility of scalp cooling, ensuring that every applicable cancer patient has the opportunity to retain their hair through chemotherapy.
Anna has been instrumental in bringing scalp cooling to markets where historically there had been little awareness of the treatment e.g. Argentina, Mexico, whilst continuing to nurture existing established markets such as the Netherlands, Brazil, Germany. Anna played a major role instigating clinical trials at the National University Hospital, Singapore and the subsequent scalp cooling relaunch following close collaboration with Key Opinion Leaders and clinicians within the oncology space.
PAXMAN achieved regulatory clearance of their scalp cooling device in Japan earlier this year. The market approval was granted by Japanese regulatory bodies, similar to the FDA in the USA and based on a successful clinical evaluation at five leading Japanese cancer clinics, testimony to Anna’s dedication and support of PAXMAN’s global partner and clinical partners in the territory.
The scalp cooling market in South Korea is another project, which is benefiting from Anna’s in depth knowledge. Following numerous market visits, she is currently involved in setting up clinical trials with PAXMAN devices, which will enhance knowledge and scalp cooling efficacy for Asian patients.
She has contributed as a keynote speaker at innumerable business launch events around the world, ensuring the latest scalp cooling news, best practice and protocols are shared across the PAXMAN network and beyond. Anna attends many major international oncology and supportive cancer care conferences around the world annually, supporting distribution partners and amplifying the scalp cooling word.
As a key member of the International trade team Anna is passionate to empower cancer patients with choice and access to scalp cooling and will continue to work closely with all partners, building awareness of scalp cooling and access to this important treatment in the years ahead.
Investment in people, biological research, clinical trials for both regulatory and marketing reasons, plus product development, is the key to PAXMAN’s future growth.
Location: World Trade Club, Level 33